Your browser doesn't support javascript.
loading
Cost effectiveness of medical devices to diagnose pre-eclampsia in low-resource settings.
McLaren, Zoë M; Sharp, Alana; Hessburg, John P; Sarvestani, Amir Sabet; Parker, Ethan; Akazili, James; Johnson, Timothy R B; Sienko, Kathleen H.
Afiliación
  • McLaren ZM; Health Management and Policy, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA.
  • Sharp A; Health Management and Policy, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA.
  • Hessburg JP; Department of Biomedical Engineering, College of Engineering, University of Michigan, 2350 Hayward St., 1109 GG Brown, Ann Arbor, MI 48109-2125USA.
  • Sarvestani AS; Design Science Program, College of Engineering, University of Michigan, 2350 Hayward St., 1109 GG Brown, Ann Arbor, MI 48109-2125, USA.
  • Parker E; Health Management and Policy, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA.
  • Akazili J; Navrongo Health Research Centre, Navrongo, Upper East, Ghana.
  • Johnson TRB; Department of Obstetrics & Gynecology, Medical School, University of Michigan, L4000 Womens SPC 5276, Ann Arbor, MI 48109-5276, USA.
  • Sienko KH; Departments of Mechanical and Biomedical Engineering, College of Engineering, University of Michigan, 2350 Hayward St., 3454 GG Brown, Ann Arbor, MI 48109-2125, USA.
Dev Eng ; 2: 99-106, 2017.
Article en En | MEDLINE | ID: mdl-29276756
BACKGROUND: Maternal mortality remains a major health challenge facing developing countries, with pre-eclampsia accounting for up to 17 percent of maternal deaths. Diagnosis requires skilled health providers and devices that are appropriate for low-resource settings. This study presents the first cost-effectiveness analysis of multiple medical devices used to diagnose pre-eclampsia in low- and middle-income countries (LMICs). METHODS: Blood pressure and proteinuria measurement devices, identified from compendia for LMICs, were included. We developed a decision tree framework to assess the cost-effectiveness of each device using parameter values that reflect the general standard of care based on a survey of relevant literature and expert opinion. We examined the sensitivity of our results using one-way and second-order probabilistic multivariate analyses. RESULTS: Because the disability-adjusted life years (DALYs) averted for each device were very similar, the results were influenced by the per-use cost ranking. The most cost-effective device combination was a semi-automatic blood pressure measurement device and visually read urine strip test with the lowest combined per-use cost of $0.2004 and an incremental cost effectiveness ratio of $93.6 per DALY gained relative to a baseline with no access to diagnostic devices. When access to treatment is limited, it is more cost-effective to improve access to treatment than to increase testing rates or diagnostic device sensitivity. CONCLUSIONS: Our findings were not sensitive to changes in device sensitivity, however they were sensitive to changes in the testing rate and treatment rate. Furthermore, our results suggest that simple devices are more cost-effective than complex devices. The results underscore the desirability of two design features for LMICs: ease of use and accuracy without calibration. Our findings have important implications for policy makers, health economists, health care providers and engineers.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Dev Eng Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Dev Eng Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos